Moderna stock toppled Monday after the Food and Drug Administration delayed authorizing its Covid vaccine in teens, citing the risk for myocarditis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,